Retractable Technologies (RVP)
XASE:RVP
Want to see RVP full AI Analyst Report?
RVP Stock Chart & Stats
$0.73
>-$0.01(-0.49%)
At close: 4:00 PM EST
$0.73
>-$0.01(-0.49%)
Day’s Range― - ―
52-Week Range$0.60 - $1.14
Previous CloseN/A
Volume39.25K
Average Volume (3M)153.51K
Market Cap
$21.35M
Enterprise Value$19.50M
Total Cash (Recent Filing)$35.62M
Total Debt (Recent Filing)$916.05K
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding29,937,159
10 Day Avg. Volume341,920
30 Day Avg. Volume153,511
Financial Highlights & Ratios
PEG Ratio-0.25
Price to Book (P/B)0.31
Price to Sales (P/S)0.60
P/FCF Ratio-3.04
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue0.52
Enterprise Value/Gross Profit264.93
Enterprise Value/Ebitda-52.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage And Strong Balance-sheet FlexibilityExtremely low debt relative to equity gives the company durable financial flexibility, lowering solvency risk and preserving options for restructuring, working-capital support, or targeted investment over the next 2–6 months without immediate refinancing pressure.
Regulatory-driven Demand For Safety DevicesStructural regulatory emphasis on needlestick safety supports steady, policy-backed demand for safety-engineered syringes. This creates a persistent addressable market and reduces reliance on cyclical elective procedures, supporting revenue durability over multiple quarters.
International Revenue ExpansionA large, recent increase in international sales shows product acceptance abroad and revenue diversification. Sustained international growth can offset domestic normalization, reduce concentration risk, and improve scale economics if maintained over coming quarters.
Bears Say
Declining Revenue And Negative MarginsSubstantially lower top line and negative gross margins indicate structural pricing pressure or cost misalignment. Persistent negative margins erode core profitability, limit reinvestment capacity, and threaten long-term viability unless cost base or pricing recovers.
Persistent Operating Cash BurnOngoing negative operating and free cash flow reduce runway and increase reliance on external funding or asset sales. Over several months this constrains R&D, commercial investment, and the ability to absorb shocks, raising execution risk for any turnaround plan.
Tariff Exposure And Strained LiquidityMaterial tariffs on China-sourced products are a structural policy risk that raise input costs and compress margins. Coupled with a low cash balance and continued losses, tariffs and dividend obligations to preferred holders strain liquidity and limit strategic flexibility.
Retractable Technologies News
RVP FAQ
What was Retractable Technologies’s price range in the past 12 months?
Retractable Technologies lowest stock price was $0.60 and its highest was $1.14 in the past 12 months.
What is Retractable Technologies’s market cap?
Retractable Technologies’s market cap is $21.35M.
When is Retractable Technologies’s upcoming earnings report date?
Retractable Technologies’s upcoming earnings report date is Aug 17, 2026 which is in 84 days.
How were Retractable Technologies’s earnings last quarter?
Retractable Technologies released its earnings results on May 18, 2026. The company reported -$0.143 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.143.
Is Retractable Technologies overvalued?
According to Wall Street analysts Retractable Technologies’s price is currently Overvalued.
Does Retractable Technologies pay dividends?
Retractable Technologies does not currently pay dividends.
What is Retractable Technologies’s EPS estimate?
Retractable Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Retractable Technologies have?
Retractable Technologies has 29,937,159 shares outstanding.
What happened to Retractable Technologies’s price movement after its last earnings report?
Retractable Technologies reported an EPS of -$0.143 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.343%.
Which hedge fund is a major shareholder of Retractable Technologies?
Currently, no hedge funds are holding shares in RVP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Retractable Technologies
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Technical Analysis
Orasure Technologies
―
Stereotaxis
―
Milestone Scientific
―
Sanara MedTech
―
Sharps Technology, Inc.
―
Ownership Overview
55.66% Insiders
2.55% Mutual Funds
2.76% Other Institutional Investors
37.08% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---